These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36951318)

  • 1. Mpox in the New York metropolitan area, Summer 2022.
    Gnanaprakasam R; Keller M; Glassman R; El-Khoury MY; Chen DS; Feola N; Feldman J; Chaturvedi V
    J Med Virol; 2023 Apr; 95(4):e28699. PubMed ID: 36951318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.
    Contag CA; Mische L; Fong I; Karan A; Vaidya A; McCormick DW; Bower W; Hacker JK; Johnson K; SanJuan P; Crebbin L; Temmins C; Sahni H; Bogler Y; Cooper JD; Narasimhan S
    Emerg Infect Dis; 2023 Dec; 29(12):2520-2523. PubMed ID: 37856215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tecovirimat for the treatment of severe Mpox in Germany.
    Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
    Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1.
    Chen WH; Axell-House DB
    J Med Virol; 2023 Sep; 95(9):e29078. PubMed ID: 37665172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical considerations on monkeypox antiviral medications: An overview.
    Pourkarim F; Entezari-Maleki T
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 40-Year-Old Man with Anemia, Proctitis, Rectal Bleeding, and a Perianal Rash Due to Mpox (Monkeypox) Infection.
    Moore C; Marcucci V; Torres P; Liu E; Parker GS
    Am J Case Rep; 2023 Sep; 24():e940177. PubMed ID: 37660250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
    Nguyen BT; Marc A; Suñer C; Marks M; Ubals M; Hernández-Rodríguez Á; Melendez MÁ; ; Hruby DE; Russo AT; Mentré F; Mitjà O; Grosenbach DW; Guedj J
    PLoS Biol; 2023 Dec; 21(12):e3002249. PubMed ID: 38127878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
    Mazzotta V; Cozzi-Lepri A; Lanini S; Mondi A; Carletti F; Tavelli A; Gagliardini R; Vita S; Pinnetti C; Aguglia C; Colavita F; Faccendini P; Matusali G; Faraglia F; Beccacece A; Paulicelli J; Girardi E; Nicastri E; Vaia F; Maggi F; Antinori A
    J Med Virol; 2023 Jun; 95(6):e28868. PubMed ID: 37306318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.
    Smith TG; Gigante CM; Wynn NT; Matheny A; Davidson W; Yang Y; Condori RE; O'Connell K; Kovar L; Williams TL; Yu YC; Petersen BW; Baird N; Lowe D; Li Y; Satheshkumar PS; Hutson CL
    Emerg Infect Dis; 2023 Dec; 29(12):2426-2432. PubMed ID: 37856204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Distribution of Tecovirimat During the Peak of the Mpox Outbreak - Los Angeles County, June 2022-January 2023.
    O'Neil MJ; Archer R; Danza P; Fisher R; Bagwell DA; Younis I; Kulkarni S; Rubin Z; Kim M; Balter S; Terashita D; Kim J; Singhal R; Hancz D; Gausche-Hill M; Shah NK
    MMWR Morb Mortal Wkly Rep; 2024 Jun; 73(24):546-550. PubMed ID: 38900699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Neonatal Monkeypox Treated With Oral Tecovirimat.
    Castejon-Ramirez S; Pennington J; Beene H; Hysmith N; Ost S
    Pediatrics; 2024 Jan; 153(1):. PubMed ID: 38148743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mpox Genital Lesions: A Large Single-center Experience With Intermediate Follow-up.
    Lee J; McLean J; Zucker J; Brandes S; Joice G
    J Urol; 2023 Sep; 210(3):510-516. PubMed ID: 37294043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists.
    Gupta AK; Talukder M; Rosen T; Piguet V
    Am J Clin Dermatol; 2023 Jul; 24(4):541-556. PubMed ID: 37106278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mpox (Monkeypox) Infection During Pregnancy.
    Sampson MM; Magee G; Schrader EA; Dantuluri KL; Bukhari A; Passaretti C; Temming L; Leonard M; Philips JB; Weinrib D
    Obstet Gynecol; 2023 May; 141(5):1007-1010. PubMed ID: 36928418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Pilot of an Mpox Severity Scoring System.
    Zucker J; McLean J; Huang S; DeLaurentis C; Gunaratne S; Stoeckle K; Glesby MJ; Wilkin TJ; Fischer W; Damon I; Brooks JT
    J Infect Dis; 2024 Mar; 229(Supplement_2):S229-S233. PubMed ID: 37956401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic targets for Mpox: the evidence to date.
    Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K
    Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.
    Fink DL; Callaby H; Luintel A; Beynon W; Bond H; Lim EY; Gkrania-Klotsas E; Heskin J; Bracchi M; Rathish B; Milligan I; O'Hara G; Rimmer S; Peters JR; Payne L; Mody N; Hodgson B; Lewthwaite P; Lester R; Woolley SD; Sturdy A; Whittington A; Johnson L; Jacobs N; Quartey J; Ai Payne B; Crowe S; Elliott IA; Harrison T; Cole J; Beard K; Cusack TP; Jones I; Banerjee R; Rampling T; ; Dunning J
    Lancet Infect Dis; 2023 May; 23(5):589-597. PubMed ID: 36566771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.